127 related articles for article (PubMed ID: 16601795)
1. Influence of carvedilol on superoxide generation and enzyme release from stimulated human neutrophils.
Macicková T; Pecivová J; Nosál' R; Holománová D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):389-92. PubMed ID: 16601795
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
Macickova T; Pecivova J; Nosal R; Lojek A; Pekarova M; Cupanikova D
Neuro Endocrinol Lett; 2008 Oct; 29(5):790-3. PubMed ID: 18987595
[TBL] [Abstract][Full Text] [Related]
3. Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity.
Pecivová J; Macicková T; Lojek A; Gallová L; Cíz M; Nosál' R; Holománová D
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():160-3. PubMed ID: 17159805
[TBL] [Abstract][Full Text] [Related]
4. No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions.
Asbrink S; Zickert A; Bratt J; Gyllenhammar H; Palmblad J
Biochem Pharmacol; 2000 Apr; 59(8):1007-13. PubMed ID: 10692566
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
Yue TL; McKenna PJ; Ruffolo RR; Feuerstein G
Eur J Pharmacol; 1992 Apr; 214(2-3):277-80. PubMed ID: 1355437
[TBL] [Abstract][Full Text] [Related]
6. On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.
Drábiková K; Jancinová V; Nosál' R; Solík P; Murín J; Holománová D
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():138-40. PubMed ID: 17159799
[TBL] [Abstract][Full Text] [Related]
7. In vitro effect of carvedilol on professional phagocytes.
Pecivová J; Macicková T; Lojek A; Gallova L; Cíz M; Nosál' R; Holománová D
Pharmacology; 2007; 79(2):86-92. PubMed ID: 17159380
[TBL] [Abstract][Full Text] [Related]
8. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
Yue TL; Mckenna PJ; Lysko PG; Gu JL; Lysko KA; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1994 Jan; 251(2-3):237-43. PubMed ID: 8149979
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells.
Nosál R; Jancinová V; Cíz M; Drábiková K; Lojek A; Fábryová V
Scand J Clin Lab Invest; 2005; 65(1):55-64. PubMed ID: 15859027
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils superoxide anion generation during carvedilol therapy in patients with stable angina.
Kowalski J; Błaszczyk J; Petecka E; Irzmański R; Kowalczyk E; Kowalska E; Cegliński T; Pawlicki L
Int J Cardiol; 2005 Jul; 102(3):397-402. PubMed ID: 16004883
[TBL] [Abstract][Full Text] [Related]
11. B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjects.
Liu S; Ngo DT; Stewart S; Horowitz JD; Chirkov YY
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):739-43. PubMed ID: 25115801
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant properties of carvedilol: inhibition of lipid peroxidation, protein oxidation and superoxide generation.
Suzuki Y; Tanaka M; Sohmiya M; Yoshida T; Okamoto K
Neurol Res; 2003 Oct; 25(7):749-53. PubMed ID: 14579794
[TBL] [Abstract][Full Text] [Related]
14. The photoprotein pholasin as a luminescence substrate for detection of superoxide anion radicals and myeloperoxidase activity in stimulated neutrophils.
Reichl S; Vocks A; Petković M; Schiller J; Arnhold J
Free Radic Res; 2001 Dec; 35(6):723-33. PubMed ID: 11811524
[TBL] [Abstract][Full Text] [Related]
15. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.
Oettl K; Greilberger J; Zangger K; Haslinger E; Reibnegger G; Jürgens G
Biochem Pharmacol; 2001 Jul; 62(2):241-8. PubMed ID: 11389884
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids.
Dandona P; Karne R; Ghanim H; Hamouda W; Aljada A; Magsino CH
Circulation; 2000 Jan; 101(2):122-4. PubMed ID: 10637196
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
Araújo Júnior RF; Garcia VB; Leitão RF; Brito GA; Miguel Ede C; Guedes PM; de Araújo AA
PLoS One; 2016; 11(2):e0148868. PubMed ID: 26891124
[TBL] [Abstract][Full Text] [Related]
18. Suppression of hyperglycemia-induced superoxide formation and endothelin-1 gene expression by carvedilol.
Horani MH; Haas MJ; Mooradian AD
Am J Ther; 2006; 13(1):2-7. PubMed ID: 16428915
[TBL] [Abstract][Full Text] [Related]
19. The role of protein kinase C and [Ca2+]i in superoxide anion synthesis and myeloperoxidase degranulation of human neutrophils.
Nagaji J
Kurume Med J; 1999; 46(3-4):157-62. PubMed ID: 10659591
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
Yue TL; McKenna PJ; Lysko PG; Ruffolo RR; Feuerstein GZ
Atherosclerosis; 1992 Dec; 97(2-3):209-16. PubMed ID: 1361324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
